Part 1: A Review and Perspective of the Regulatory Guidance to Support Designation and Justification of API Starting Material
Autor: | Steven Pfeiffer, John D. Orr, Maciej Smulkowski, Carl A. Busacca, Fred Hicks, William F. Kiesman, Margaret M. Faul, Magnus C. Eriksson |
---|---|
Rok vydání: | 2014 |
Předmět: | |
Zdroj: | Organic Process Research & Development. 18:587-593 |
ISSN: | 1520-586X 1083-6160 |
Popis: | Designation and justification of active pharmaceutical ingredient starting material (API SM) is a standard part of the drug substance (DS) development and commercialization process. However, current industry practices are not well understood and vary, depending on the individual company’s interpretation of regulatory guidelines. In addition, regulators are also applying varying interpretations to the designation of API SMs, further complicating progress in this arena. To increase the understanding of the strategies employed in selection and justification of API SMs the authors, members of the API and Analytical Leadership Groups of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), completed a broad industry survey of this topic among the 35 IQ Consortium member companies. To put the results of this survey into context, an understanding of the historical development of API SM regulations and the industry perspective is important and is summarized collectively for t... |
Databáze: | OpenAIRE |
Externí odkaz: |